Device Connectivity Set to Drive Major Care Change for Millions of COPD Patients
February 9, 2017 | ABI ResearchEstimated reading time: 1 minute
Chronic respiratory diseases—asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD)—affect up to one billion patients globally. While in the past, clinicians monitored patients’ vitals through regular checkups, new wearable technology now allows them to track this information remotely. ABI Research forecasts device connectivity will drive new chronic respiratory disease wearable form factors, with shipments to grow from three million shipments in 2017 to 12 million in 2022.
COPD, alone, costs U.S. healthcare systems $50 billion per year. ABI Research forecasts the U.S. will spend the most on chronic respiratory disease wearables, accounting for $6 million in 2022 of $21 million in global market revenues. Following the U.S., Europe and the Asia Pacific will also see high adoption rates. As the nascent market gains momentum, the devices will gradually shift from wireless finger-clips to wrist-worn devices.
“Wrist-worn chronic respiratory disease wearables are the ideal form factor, because they allow patients to carry out daily activities uninterrupted while collecting data continuously and in real time to note any subtle fluctuations in oxygen levels,” says Stephanie Lawrence, Research Analyst at ABI Research. “Finger-clip devices must be manually attached and activated throughout the day to provide one-off readings. Though they still provide more information than pulse oximeters in a clinical setting, finger-clip devices often miss subtle fluctuations that could indicate worsening conditions.”
Non-invasive medical monitoring solutions developer Nonin Medical’s latest wrist-worn pulse oximeter—WristOx 2, Model 3150—measures patients’ oxygen saturation and pulse rates, transmitting the data using Bluetooth 2.0. Additionally, medical device manufacturer and startup Oxitone Medical recently released its Oxitone wrist pulse oximeter that continuously monitors blood oxygen levels and sends the data to an app via embedded Bluetooth Smart.
Challenges vendors need to overcome as the market develops include meeting medical regulatory standards. The mandatory standards are critical, as they are clear proof that the device is an effective and accurate form of monitoring a patient’s condition. As obtaining medical regulation is a lengthy process, manufacturers must consider it in the early design stage as the global market develops.
Suggested Items
Real Time with... IPC APEX EXPO 2024: A Passion for Inkjet Solder Mask Technology
05/15/2024 | Real Time with...IPC APEX EXPODon Monn, national sales manager for Electra Polymers, discusses his transition to Electra and the benefits of inkjet solder mask technology. He emphasizes the significance of product passion and understanding customer issues. Don also outlines Electra's mission and expansion plans, and addresses the current state of the PCB market and the importance of education.
SiPearl: Partnership with Samsung Electronics for built-in HBM in Rhea
05/14/2024 | BUSINESS WIRESiPearl, the company building the high-performance low-power European microprocessor for HPC and AI inference, has signed a partnership with Samsung Electronics Co. Ltd., a world leader in advanced memory technology, to equip its Rhea series with Samsung’s advanced memory solution ideal for HPC and AI applications.
LPKF is Ready for Increasing Demand for Glass Substrates in the Semiconductor Industry
05/13/2024 | LPKFThe semiconductor industry is shifting towards glass to package the most advanced semiconductor chips. LPKF’s mature LIDE technology is enabling that transition into this new era from ramp-up to high volume manufacturing.
Kitron Initiates Share Buyback
05/13/2024 | KitronKitron ASA initiates a share buyback in connection with remuneration to the board members.
PC Client CPU Shipments in 1Q24 Up 33% YoY
05/10/2024 | Jon Peddie ResearchJon Peddie Research reports the growth of the global PC client-based CPU units market reached 62 million units in Q1’24, a decrease of -9.4% quarter to quarter and a 33% growth from Q1’23.